Total planned funding: $774,317,673
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $156,430,706 |
Nigeria | $138,488,227 |
South Africa | $73,423,386 |
Uganda | $71,863,522 |
Ethiopia | $69,864,786 |
Zambia | $52,807,555 |
Tanzania | $42,914,743 |
Côte d'Ivoire | $36,771,314 |
Mozambique | $29,018,670 |
Botswana | $20,305,000 |
Rwanda | $19,654,902 |
Vietnam | $18,235,619 |
Namibia | $10,530,177 |
Haiti | $10,059,266 |
Caribbean Region | $9,364,409 |
Zimbabwe | $8,130,000 |
Guyana | $5,080,664 |
Malawi | $657,000 |
Eswatini | $320,000 |
Lesotho | $176,578 |
China | $100,000 |
South Sudan | $77,000 |
Cambodia | $44,149 |
Organizational Types
Unknown | $361,120,943 |
Private Contractor | $227,820,750 |
NGO | $69,630,823 |
University | $45,556,431 |
FBO | $35,522,133 |
Host Country Government Agency | $24,661,898 |
Implementing Agency | $6,305,000 |
Own Agency | $2,007,936 |
Parastatal | $1,164,000 |
Other USG Agency | $527,759 |
Program Areas
Treatment | $774,317,673 |
Budget Codes
HTXD: Treatment: ARV Drugs | $774,317,673 |
Top Partner Programs
Management Sciences for Health:
$22,820,578
View countries